Weight-Based Insulin During and After Intravenous Insulin Infusion Reduces Rates of Rebound Hyperglycemia When Transitioning to Subcutaneous Insulin in the Medical Intensive Care Unit
- 20 October 2021
- journal article
- research article
- Published by Elsevier BV in Endocrine Practice
- Vol. 28 (2), 173-178
- https://doi.org/10.1016/j.eprac.2021.10.003
Abstract
No abstract availableKeywords
Funding Information
- Lerner Research Institute, Cleveland Clinic
- Cleveland Clinic
This publication has 24 references indexed in Scilit:
- Converting Continuous Insulin Infusion to Subcutaneous Insulin Glargine After Cardiac Surgery Using Percentage-Based Versus Weight-Based Dosing: A Pilot TrialAnnals of Pharmacotherapy, 2013
- Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patientsCritical Care Medicine, 2012
- Comparison of 70/30 Biphasic Insulin With Glargine/Lispro Regimen in Non–Critically Ill Diabetic Patients on Continuous Enteral Nutrition TherapyNutrition in Clinical Practice, 2011
- Comparison of 3 Algorithms for Basal Insulin in Transitioning from Intravenous to Subcutaneous Insulin in Stable Patients after Cardiothoracic SurgeryEndocrine Practice, 2011
- Transition From Intravenous to Subcutaneous InsulinDiabetes Care, 2011
- Maintaining glycemic control when transitioning from infusion insulin: A protocol‐driven, multidisciplinary approachJournal of Hospital Medicine, 2010
- Hyperglycemia–related mortality in critically ill patients varies with admission diagnosis*Critical Care Medicine, 2009
- Insulin Therapy and Glycemic Control in Hospitalized Patients With Diabetes During Enteral Nutrition TherapyDiabetes Care, 2009
- Intensive versus Conventional Glucose Control in Critically Ill PatientsThe New England Journal of Medicine, 2009
- Bridge over troubled waters: Safe and effective transitions of the inpatient with hyperglycemiaJournal of Hospital Medicine, 2008